Muenzer J - Search Results

1

Evaluation of the long-term treatment effects of intravenous idursulfase in patients with mucopolysaccharidosis II (MPS II) using statistical modeling: data from the Hunter Outcome Survey (HOS).

Muenzer J, Botha J, Harmatz P, Giugliani R, Kampmann C, Burton BK. Muenzer J, et al. Orphanet J Rare Dis. 2021 Oct 30;16(1):456. doi: 10.1186/s13023-021-02052-4. Orphanet J Rare Dis. 2021. PMID: 34717704 Free PMC article.

2

Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): a preliminary report.

Muenzer J, Lamsa JC, Garcia A, Dacosta J, Garcia J, Treco DA. Muenzer J, et al. Acta Paediatr Suppl. 2002;91(439):98-9. doi: 10.1111/j.1651-2227.2002.tb03115.x. Acta Paediatr Suppl. 2002. PMID: 12572850 Review.

3

A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome).

Muenzer J, Wraith JE, Beck M, Giugliani R, Harmatz P, Eng CM, Vellodi A, Martin R, Ramaswami U, Gucsavas-Calikoglu M, Vijayaraghavan S, Wendt S, Puga AC, Ulbrich B, Shinawi M, Cleary M, Piper D, Conway AM, Kimura A. Muenzer J, et al. Genet Med. 2006 Aug;8(8):465-73. doi: 10.1097/01.gim.0000232477.37660.fb. Genet Med. 2006. PMID: 16912578 Free article. Clinical Trial.

4

A phase I/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome).

Muenzer J, Gucsavas-Calikoglu M, McCandless SE, Schuetz TJ, Kimura A. Muenzer J, et al. Mol Genet Metab. 2007 Mar;90(3):329-37. doi: 10.1016/j.ymgme.2006.09.001. Epub 2006 Dec 20. Mol Genet Metab. 2007. PMID: 17185020 Clinical Trial.

5

Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome).

Martin R, Beck M, Eng C, Giugliani R, Harmatz P, Muñoz V, Muenzer J. Martin R, et al. Among authors: muenzer j. Pediatrics. 2008 Feb;121(2):e377-86. doi: 10.1542/peds.2007-1350. Pediatrics. 2008. PMID: 18245410 Review.

6

Hunter syndrome: to treat or not to treat.

Muenzer J, Martins AM. Muenzer J, et al. Acta Paediatr. 2008 Apr;97(457):55-6. doi: 10.1111/j.1651-2227.2008.00644.x. Acta Paediatr. 2008. PMID: 18339189 No abstract available.

7

Initial report from the Hunter Outcome Survey.

Wraith JE, Beck M, Giugliani R, Clarke J, Martin R, Muenzer J; HOS Investigators. Wraith JE, et al. Among authors: muenzer j. Genet Med. 2008 Jul;10(7):508-16. doi: 10.1097/gim.0b013e31817701e6. Genet Med. 2008. PMID: 18580692

8

Mucopolysaccharidosis I: management and treatment guidelines.

Muenzer J, Wraith JE, Clarke LA; International Consensus Panel on Management and Treatment of Mucopolysaccharidosis I. Muenzer J, et al. Pediatrics. 2009 Jan;123(1):19-29. doi: 10.1542/peds.2008-0416. Pediatrics. 2009. PMID: 19117856

9

Mortality and cause of death in mucopolysaccharidosis type II-a historical review based on data from the Hunter Outcome Survey (HOS).

Jones SA, Almássy Z, Beck M, Burt K, Clarke JT, Giugliani R, Hendriksz C, Kroepfl T, Lavery L, Lin SP, Malm G, Ramaswami U, Tincheva R, Wraith JE; HOS Investigators. Jones SA, et al. J Inherit Metab Dis. 2009 Aug;32(4):534-43. doi: 10.1007/s10545-009-1119-7. Epub 2009 Jul 14. J Inherit Metab Dis. 2009. PMID: 19597960

10

Multidisciplinary management of Hunter syndrome.

Muenzer J, Beck M, Eng CM, Escolar ML, Giugliani R, Guffon NH, Harmatz P, Kamin W, Kampmann C, Koseoglu ST, Link B, Martin RA, Molter DW, Muñoz Rojas MV, Ogilvie JW, Parini R, Ramaswami U, Scarpa M, Schwartz IV, Wood RE, Wraith E. Muenzer J, et al. Pediatrics. 2009 Dec;124(6):e1228-39. doi: 10.1542/peds.2008-0999. Epub 2009 Nov 9. Pediatrics. 2009. PMID: 19901005 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

155 results

Search Page